Tango Therapeutics TNGX
NASDAQ TNGX
$24.42 +0.12 (+0.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Common Equity (2020 - 2026)

Updated

Tango Therapeutics (TNGX) reported Common Equity of $1.02 billion for Q2 2026, up 659.2% from $134.95 million a year earlier and up 161.7% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Tango Therapeutics posted Common Equity of $346.18 million, up 73.5% from FY2024.

  • Common Equity has a five-year compound annual growth rate of 55.1% (FY2020 to FY2025).
  • By year, Common Equity came in at $199.52 million in FY2024 (-21.2%), $253.11 million in FY2023 (+1.5%), $249.48 million in FY2022 (-27.6%) and $344.75 million in FY2021 (+793.1%).
  • The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q2 2020.
  • Year over year, Common Equity has now increased in each of the last three quarters, with growth averaging 89.6% over the last eight quarters.
  • The high point for year-over-year Common Equity in five years was Q4 2021 (growth of 793.1%); the low point was Q2 2025 (a decline of 45.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $391.51 million (Q1 2026), $346.18 million (Q4 2025) and $160.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Tango Therapeutics 4.09 Bn 2.20 Bn - 1.02 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Bn
Mar 31, 2026 391.51 Mn
Dec 31, 2025 346.18 Mn
Sep 30, 2025 160.03 Mn
Jun 30, 2025 134.95 Mn
Mar 31, 2025 166.76 Mn
Dec 31, 2024 199.52 Mn
Sep 30, 2024 229.17 Mn
Jun 30, 2024 247.67 Mn
Mar 31, 2024 264.45 Mn
Dec 31, 2023 253.11 Mn
Sep 30, 2023 276.60 Mn
Jun 30, 2023 212.95 Mn
Mar 31, 2023 227.26 Mn
Dec 31, 2022 249.48 Mn
Sep 30, 2022 273.07 Mn
Jun 30, 2022 298.70 Mn
Mar 31, 2022 320.36 Mn
Dec 31, 2021 344.75 Mn
Sep 30, 2021 365.41 Mn
API Access

Tango Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=TNGX&period=max&api_key=YOUR_API_KEY